A Tonsillar PolyICLC/AT-2 SIV Therapeutic Vaccine Maintains Low Viremia Following Antiretroviral Therapy Cessation

BACKGROUND: HIV-infected individuals rely on antiretroviral therapy (ART) to control viral replication. Despite abundant demonstrable benefits, the multiple limitations of ART point to the potential advantages of therapeutic vaccination approaches that could provide sustained host control of viral r...

Descripción completa

Detalles Bibliográficos
Autores principales: Vagenas, Panagiotis, Aravantinou, Meropi, Williams, Vennansha G., Jasny, Edith, Piatak, Michael, Lifson, Jeffrey D., Salazar, Andres M., Blanchard, James L., Gettie, Agegnehu, Robbiani, Melissa
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2010
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2943484/
https://www.ncbi.nlm.nih.gov/pubmed/20877632
http://dx.doi.org/10.1371/journal.pone.0012891

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2943484/
https://www.ncbi.nlm.nih.gov/pubmed/20877632
http://dx.doi.org/10.1371/journal.pone.0012891

Ejemplares similares